TMDX
TransMedics Group, Inc. · Healthcare
Director David Weill sold $693K of TransMedics Group, Inc.
Sold$693,200
$138.64Price
5,000Shares
−29%Stake
What TMDX did after the filing
- The stock from Fri, Dec 5 close, $136.51
- −2.0%
- S&P 500, same days
- +0.8%
Measured over 30 trading days, to the Jan 21 close.
Traded Wed, Dec 3. Filed Fri, Dec 5, 11:30 AM ET, during the session. Returns use the Dec 5 close and the Jan 21 close. Not investment advice.